JP2023538409A5 - - Google Patents
Info
- Publication number
- JP2023538409A5 JP2023538409A5 JP2023512464A JP2023512464A JP2023538409A5 JP 2023538409 A5 JP2023538409 A5 JP 2023538409A5 JP 2023512464 A JP2023512464 A JP 2023512464A JP 2023512464 A JP2023512464 A JP 2023512464A JP 2023538409 A5 JP2023538409 A5 JP 2023538409A5
- Authority
- JP
- Japan
- Prior art keywords
- aav
- cells
- recombinant
- nucleic acid
- acid molecule
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB2013057.1 | 2020-08-21 | ||
| GBGB2013057.1A GB202013057D0 (en) | 2020-08-21 | 2020-08-21 | Method of making recombinant aavs |
| PCT/GB2021/052162 WO2022038369A1 (en) | 2020-08-21 | 2021-08-20 | Method of making recombinant aavs |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023538409A JP2023538409A (ja) | 2023-09-07 |
| JP2023538409A5 true JP2023538409A5 (enExample) | 2024-08-21 |
| JP7853958B2 JP7853958B2 (ja) | 2026-04-30 |
Family
ID=72660685
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023512464A Active JP7853958B2 (ja) | 2020-08-21 | 2021-08-20 | 組み換えａａｖの作製方法 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20240026378A1 (enExample) |
| EP (1) | EP4200428B1 (enExample) |
| JP (1) | JP7853958B2 (enExample) |
| KR (1) | KR20230074485A (enExample) |
| CN (1) | CN116419974A (enExample) |
| AU (1) | AU2021327855A1 (enExample) |
| CA (1) | CA3189844A1 (enExample) |
| GB (1) | GB202013057D0 (enExample) |
| MX (1) | MX2023001936A (enExample) |
| WO (1) | WO2022038369A1 (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110892064A (zh) | 2017-07-25 | 2020-03-17 | 牛津遗传学有限公司 | 腺病毒载体 |
| GB201901571D0 (en) | 2019-02-05 | 2019-03-27 | Oxford Genetics Ltd | Inducible AAV sysyem |
| US12054738B2 (en) | 2020-07-30 | 2024-08-06 | Shape Therapeutics Inc. | Stable cell lines for inducible production of rAAV virions |
| TW202323529A (zh) | 2021-10-18 | 2023-06-16 | 美商再生元醫藥公司 | 包括腺病毒相關病毒聚核苷酸的真核細胞 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2453405A1 (en) | 2001-07-13 | 2003-01-23 | University Of Iowa Research Foundation | Pseudotyped adeno-associated viruses and uses thereof |
| AU2003274397A1 (en) | 2002-06-05 | 2003-12-22 | University Of Florida | Production of pseudotyped recombinant aav virions |
| AU2003265855A1 (en) | 2002-08-28 | 2004-03-19 | University Of Florida | Modified aav |
| WO2009137006A2 (en) * | 2008-04-30 | 2009-11-12 | The University Of North Carolina At Chapel Hill | Directed evolution and in vivo panning of virus vectors |
| CN110892064A (zh) | 2017-07-25 | 2020-03-17 | 牛津遗传学有限公司 | 腺病毒载体 |
| FR3069668B1 (fr) | 2017-07-27 | 2021-02-12 | Safran | Procede et dispositif de recherche d'un defaut susceptible d'affecter un dispositif mecanique tournant de transmission de puissance |
-
2020
- 2020-08-21 GB GBGB2013057.1A patent/GB202013057D0/en not_active Ceased
-
2021
- 2021-08-20 MX MX2023001936A patent/MX2023001936A/es unknown
- 2021-08-20 US US18/021,675 patent/US20240026378A1/en active Pending
- 2021-08-20 WO PCT/GB2021/052162 patent/WO2022038369A1/en not_active Ceased
- 2021-08-20 JP JP2023512464A patent/JP7853958B2/ja active Active
- 2021-08-20 CN CN202180067893.XA patent/CN116419974A/zh active Pending
- 2021-08-20 KR KR1020237009622A patent/KR20230074485A/ko active Pending
- 2021-08-20 EP EP21759123.9A patent/EP4200428B1/en active Active
- 2021-08-20 CA CA3189844A patent/CA3189844A1/en active Pending
- 2021-08-20 AU AU2021327855A patent/AU2021327855A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023538409A5 (enExample) | ||
| JP2023076606A5 (enExample) | ||
| JP2022507534A5 (enExample) | ||
| JP7601339B2 (ja) | Ａａｖを産生する方法 | |
| JP2023123765A5 (enExample) | ||
| EP4200428B1 (en) | Method of making recombinant aavs | |
| JP2024517104A5 (enExample) | ||
| JP2023510590A5 (enExample) | ||
| EP4326881A1 (en) | Dna amplification method using care elements | |
| EP4317424A1 (en) | Vector, method for preparing linear covalent bond closed dna using same, parvovirus vector preparation method, and parvovirus vector producing cell | |
| JP2024523891A5 (enExample) | ||
| JP2023546116A5 (enExample) | ||
| JP7834758B2 (ja) | 低レベルのｖａ－ｒｎａを有する産生細胞 | |
| WO2024143440A1 (ja) | アデノ随伴ウイルスの製造方法、およびベクターのセット | |
| WO2024075819A1 (ja) | 細胞を用いたウイルスベクターの生産方法 | |
| WO2023074877A1 (ja) | 細胞添加用組成物 | |
| US20260022401A1 (en) | Novel AAV rep ORFs and Rep polypeptides | |
| HK40096036A (en) | Method of making recombinant aavs | |
| HK40096036B (en) | Method of making recombinant aavs | |
| CN121816424A (zh) | 用于生产基于腺相关病毒(AAV)的载体(变体)的腺病毒E2a基因的修饰的序列 | |
| Lunev et al. | COMPARATIVE ANALYSIS OF ADENO-ASSOCIATED VIRUS SEROTYPES FOR IN VITRO ASSESSMENT OF GNAO1 ENCEPHALOPATHY GENE THERAPY | |
| WO2026003353A1 (en) | Genetic constructs for improved aav titers and potency | |
| EP4671265A1 (en) | GENETIC CONSTRUCTIONS FOR ENHANCED AAV TITLES AND ASSOCIATED USEFUL POWER | |
| KR20260052122A (ko) | 아데노-연관 바이러스(AAV) 기반 벡터의 생산을 위한 아데노바이러스 E2a 유전자의 변형된 서열 (변이체) | |
| CN120138052A (zh) | 一种用于生产高质量重组腺相关病毒的Cap和Rep蛋白双重调控系统及其构建方法 |